Next Article in Journal
Unusual Presentation of Metastatic Sebaceous Crcinoma and Its Response to Chemotherapy: Is Genotyping a Right Answer for Guiding Chemotherapy in Rare Tumours?
Previous Article in Journal
Fertility Preservation in Reproductive-Age Women Facing Gonadotoxic Treatments
 
 
Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Eastern Canadian Gastrointestinal Cancer Consensus Conference 2014

1
The Ottawa Hospital Cancer Centre, Ottawa, ON, Canada
2
Hôpital de la Cité-de-la-Santé de Laval, Laval, QC, Canada
3
Queen’s University, Kingston, ON, Canada
4
Mount Sinai Hospital, Toronto, ON, Canada
5
Monteregie Cancer Centre, Charles-LeMoyne Hospital, Longueil, QC, Canada
6
Dalhousie University, Halifax, NS, Canada
7
Centre de Santé et de Services sociaux de SeptÎles, Sept-Îles, QC, Canada
8
Centre hospitalier de l’Université de Montréal, Montreal, QC, Canada
9
McGill University Health Centre, Montreal, QC, Canada
*
Author to whom correspondence should be addressed.
Curr. Oncol. 2015, 22(4), 305-315; https://doi.org/10.3747/co.22.2603
Submission received: 7 May 2015 / Revised: 12 June 2015 / Accepted: 8 July 2015 / Published: 1 August 2015

Abstract

The annual Eastern Canadian Colorectal Cancer Consensus Conference was held in Montreal, Quebec, 23–25 October 2014. Expert radiation, medical, and surgical oncologists and pathologists involved in the management of patients with gastrointestinal malignancies participated in presentations and discussions resulting in consensus statements on such hot topics as management of neuroendocrine tumours, advanced and metastatic pancreatic cancer, and metastatic colorectal cancer.
Keywords: Neuroendocrine tumours; pancreatic cancer; colorectal cancer; screening; chemotherapy; radiation therapy; RAS testing Neuroendocrine tumours; pancreatic cancer; colorectal cancer; screening; chemotherapy; radiation therapy; RAS testing

Share and Cite

MDPI and ACS Style

Tsvetkova, E.; Sud, S.; Aucoin, N.; Biagi, J.; Burkes, R.; Samson, B.; Brule, S.; Cripps, C.; Colwell, B.; Falkson, C.; et al. Eastern Canadian Gastrointestinal Cancer Consensus Conference 2014. Curr. Oncol. 2015, 22, 305-315. https://doi.org/10.3747/co.22.2603

AMA Style

Tsvetkova E, Sud S, Aucoin N, Biagi J, Burkes R, Samson B, Brule S, Cripps C, Colwell B, Falkson C, et al. Eastern Canadian Gastrointestinal Cancer Consensus Conference 2014. Current Oncology. 2015; 22(4):305-315. https://doi.org/10.3747/co.22.2603

Chicago/Turabian Style

Tsvetkova, E., S. Sud, N. Aucoin, J. Biagi, R. Burkes, B. Samson, S. Brule, C. Cripps, B. Colwell, C. Falkson, and et al. 2015. "Eastern Canadian Gastrointestinal Cancer Consensus Conference 2014" Current Oncology 22, no. 4: 305-315. https://doi.org/10.3747/co.22.2603

APA Style

Tsvetkova, E., Sud, S., Aucoin, N., Biagi, J., Burkes, R., Samson, B., Brule, S., Cripps, C., Colwell, B., Falkson, C., Dorreen, M., Goel, R., Halwani, F., Maroun, J., Michaud, N., Tehfe, M., Thirlwell, M., Vickers, M., & Asmis, T. (2015). Eastern Canadian Gastrointestinal Cancer Consensus Conference 2014. Current Oncology, 22(4), 305-315. https://doi.org/10.3747/co.22.2603

Article Metrics

Back to TopTop